An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY

NCT03419000 ·Status: COMPLETED ·Phase: NA

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

NCT01191086 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

NCT00235755 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia

NCT05502549 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants

NCT05499260 ·Status: UNKNOWN ·Phase: PHASE1

Assessment of Suicidality in Epilepsy - Rating Tools

NCT01085461 ·Status: COMPLETED

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

NCT03283371 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

NCT01147003 ·Status: COMPLETED ·Phase: PHASE2

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

NCT07141329 ·Status: RECRUITING ·Phase: PHASE2

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00425282 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

NCT01142193 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

NCT02408549 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118962 ·Status: COMPLETED ·Phase: PHASE2

Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.

NCT05346666 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

NCT04938427 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00433667 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

NCT00887861 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

NCT00220415 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

NCT00292461 ·Status: COMPLETED ·Phase: PHASE3